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Pretransplant predictors of early mortality of liver transplantationAfter nearly five decades of persistent exertion, liver
transplantation (LT) has become a recognized and definite
therapy with a highly successful outcome for various liver
diseases, such as end-stage cirrhosis of the liver, acute liver
failure, various metabolic diseases, and hepatic malignancy.
The areas where major progress has been made, resulting in
improvements in disease management, include refinements to
surgical techniques, advances in critical care, and in particular,
better immunosuppressive medication. Correspondingly,
improved techniques for splitting the livers of deceased grafts
and for carrying out live donor grafts have also played an
important role over the past two decades in providing cures for
many patients who have been waiting for LT from the
deceased-donor waiting list.1,2 Many of these patients would
have dropped off the list without these improvements. How-
ever, early mortality after LT still occurs even in the modern
era. Identifying the predictors of early mortality after LT is an
important issue that will allow the aggressive management of
such potential events and help to minimize or even prevent
these tragedies.3e6
The causes of early or 30-day mortality after LT are varied
and should be classified into three categories: donor factors,
recipient factors, and operative factors (Table 1). The partic-
ular type of LT, either deceased donor or living related donor,
also has some impact on early mortality. In terms of donor
factors, poor-quality or so-called marginal grafts from
deceased donors, grafts that are small in size, and partial grafts
with a complicated anatomy from live donors seem to cause
primary nonfunction or severe dysfunction of the implanted
graft, which then leads to graft failure and patient death. ABO-
incompatible grafts also show a higher rate of graft failure. InTable 1
The preoperative and operative causes of early mortality after liver transplantation
Donor factors Recipient factors
1. Deceased or live donor
2. Cold and warm ischemic time
3. Quality of graft: steatosis or fibrosis
4. Age of donor
1. Severity of clinical cond
encephalopathy, poor kidn
condition, poor lung or he
5. Size of graft: small or large size
6. Vascular anatomy or biliary anatomy of graft
7. Whole liver or partial liver
2. Vascular conditions: por
hepatic artery quality and
causes to early graft failur
8. ABO-compatible or not graft 3. High portal flow or port
graft dysfunction
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ditiondsuch as having a poor quality of hepatic artery, reverse
portal flow with expanded portosystemic shunting, or a small
or sclerotic portal veindpose substantial challenges to sur-
geons. Some transplant centers will abandon LT as a treatment
for these patients. In addition to the vascular condition of the
recipient, the severity of the recipient’s illness prior to LT also
influences the surgical outcome. Some patients are too ill to
benefit from an LT. Under such circumstances, it is very dif-
ficult for surgeons and family to decide as to whether such a
patient, who is extremely ill even under full medical support,
should even have an LT. In terms of operative factors, massive
intraoperative blood loss and technical failures, such as hep-
atic artery thrombosis, portal vein thrombosis, and hepatic
vein thrombosis, are all well-documented prognostic factors
with respect to early mortality.7,8
If the severity of a recipient’s clinical illness is considered,
the absolute contraindications with respect to LT for an
aggressive transplant team are fewdonly brain death, severe
hypoxemia under ventilation, and severe hypotension under
vasopressors are absolute contraindications.9 Nevertheless,
there are a number of relative contraindications indicating that
the risk of LT early mortality is elevated when recipients have
these conditions. However, under such circumstances, whether
LT is completed or not is highly dependent on the attitude of the
family, available hospital resources, and the LT policy of both
the country and the transplant team itself. Ranking high on the
list of relative contraindications are high-grade encephalopathy,
septicemia with stable vital signs but not under appropriate
medical control, poor cardiac function, severe hepatopulmo-
nary syndrome, and severe pulmonary hypertension.10.
Operative factors
ition, such as severe
ey function, septic
art function
1. Successful or unsuccessful reconstructions
of graft vessels
tal vein thrombosis,
small portal vein are all
e
2. Hemodynamic stability during operation
al pressure causes early 3. Intraoperative blood loss
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patients in order to identify pretransplant factors that predict
early LT mortality. The authors divided their patients into two
groups: a deceased donor group (DDLT) and a living donor
group (LDLT). They concluded that severe hepatic encephal-
opathy (grade 3) in the DDLT and an abnormal serum crea-
tinine level in the LDLT were the significant pretransplant
variables related to early death after LT. In reality, the allo-
cation system for deceased donor livers is largely dependent
on the health status severity of the recipients, and therefore the
mortality rate for the DDLT group was much higher than that
for the LDLT group. A particularly high mortality rate was
noted when fulminant hepatic failure was present, which is
almost always associated with severe hepatic encephalopathy.
When the LDLT patient characteristics were examined, the
serum creatinine level of these patients was not particularly
high (mean  SD, 1.0  0.5). The appropriate cutoff value for
the serum creatinine level and how such a value is decided
were not well described in this article. Under such circum-
stances, practitioners should be very careful not to over-
interpret the findings from this study.Conflicts of interest
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